Walder Wyss advised the shareholders of HUBERLAB.AG on the sale to Calibre Scientific. The team was led by Alexander Gutmans (Partner, Corporate/M&A and Venture Capital - pictured) and included Robert Desax (Partner,
Tags :Karina Tschon
Walder Wyss advises Boehringer Ingelheim. The team was led by Alexander Gutmans (Partner, Corporate/M&A and Venture Capital - pictured left) and Robert von Rosen (Partner, Corporate/M&A and Venture Capital). VISCHER advised
VISCHER is advising Noema Pharma in this transaction. The team is led by Matthias Staehelin (Corporate, pictured left). Walder Wyss advised Gilde Healthcare Partners, Polaris Partners, Invus Capital and BioMedInvest as investors. The team included
The team included Alexander Gutmans (Partner, Corporate/M&A and Venture Capital - pictured), Robert von Rosen (Partner, Corporate/M&A and Venture Capital) and Karina Tschon (Associate, Corporate/M&A and Venture Capital).
The team included Alexander Gutmans (Partner, Corporate/M&A and Venture Capital - pictured) and Karina Tschon (Associate, Corporate/M&A and Venture Capital).
The team was led by Alexander Gutmans (Partner, Transaction/M&A & Venture Capital) and Robert von Rosen (Partner, Transaction/M&A & Venture Capital) and included Ayesha Curmally (Partner, Notary Services), Jessica Aeschbach Flórez (Senior
The team was led by partner Alexander Gutmans (Transaction/M&A & Venture Capital - pictured) and partner Robert von Rosen (Transaction/M&A & Venture Capital)